Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/18/2025

Management of Gram-Positive Cocci in Chains Bacteremia

Initial Assessment and Empiric Therapy

  • The Infectious Diseases Society of America recommends obtaining at least two sets of blood cultures before initiating antimicrobial therapy to establish the diagnosis and guide treatment 1
  • For empiric coverage of gram-positive cocci in chains, the American College of Physicians suggests selecting therapy based on local resistance patterns and patient risk factors, with vancomycin as an option for suspected methicillin-resistant strains 1, 2
  • For beta-lactam-susceptible strains, penicillin G remains the drug of choice with cefazolin as an alternative, according to the Clinical Infectious Diseases guidelines 2
  • If the patient is critically ill, has sepsis, or is neutropenic, the Infectious Diseases Society of America recommends considering combination therapy with an agent effective against gram-negative bacilli 3

Targeted Therapy Based on Identification and Susceptibility

  • For vancomycin-susceptible Enterococcus faecalis, the Infectious Diseases Society of America suggests ampicillin or penicillin plus gentamicin for synergy in complicated cases 3
  • For vancomycin-resistant enterococci, the Clinical Infectious Diseases guidelines recommend linezolid or daptomycin 4
  • For enterococcal bloodstream infections, combination therapy with ampicillin and gentamicin may be more effective than monotherapy when the catheter is retained, according to the Infectious Diseases Society of America 3

Catheter Management

  • The Clinical Infectious Diseases guidelines recommend obtaining blood cultures from both the catheter and peripherally to measure differential time to positivity (DTTP) 5
  • A DTTP of ≥2 hours is highly sensitive and specific for catheter-related bacteremia, according to the Annals of Oncology 5
  • Long-term catheters should be removed in patients with severe sepsis, suppurative thrombophlebitis, endocarditis, or persistent bacteremia despite >72 hours of appropriate antimicrobial therapy, as recommended by the Infectious Diseases Society of America 1, 3

Duration of Therapy

  • For uncomplicated bacteremia with source control, the Praxis Medical Insights guidelines recommend 7-14 days of therapy 4
  • For complicated infections, the Clinical Infectious Diseases guidelines suggest 4-6 weeks of therapy 1
  • When denoting duration of antimicrobial therapy, day 1 is the first day on which negative blood culture results are obtained, according to the Infectious Diseases Society of America 1

Special Considerations

  • For patients with renal impairment, the Praxis Medical Insights guidelines recommend adjusting dosing of vancomycin and other renally cleared antibiotics 4
  • For hemodialysis patients, vancomycin can be dosed after each dialysis session, according to the Praxis Medical Insights guidelines 4
  • The Infectious Diseases Society of America recommends considering antibiotic lock therapy for catheter salvage in appropriate cases 1
  • The Praxis Medical Insights guidelines suggest monitoring vancomycin levels in patients with impaired renal function to avoid toxicity 2

Common Pitfalls to Avoid

  • Using vancomycin empirically when not indicated contributes to development of resistance, according to the Praxis Medical Insights guidelines 2
  • Continuing vancomycin when cultures are negative for beta-lactam-resistant organisms is not recommended by the Praxis Medical Insights guidelines 2
  • Delaying appropriate therapy for severe infections increases mortality, as noted by the Praxis Medical Insights guidelines 2
  • Using linezolid for empirical therapy in patients suspected but not proven to have bacteremia is not recommended by the Clinical Infectious Diseases guidelines 1